Cargando…
Systemic Causes of Cholestasis
Systemic causes of cholestasis constitute a diverse group of diseases across organ systems. The pathophysiology of cholestasis in systemic disease can be a consequence of direct involvement of a disease process within the liver or extrahepatic biliary system or secondary to immune-mediated changes i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378837/ https://www.ncbi.nlm.nih.gov/pubmed/23540504 http://dx.doi.org/10.1016/j.cld.2012.11.001 |
_version_ | 1782364095650988032 |
---|---|
author | deLemos, Andrew S. Friedman, Lawrence S. |
author_facet | deLemos, Andrew S. Friedman, Lawrence S. |
author_sort | deLemos, Andrew S. |
collection | PubMed |
description | Systemic causes of cholestasis constitute a diverse group of diseases across organ systems. The pathophysiology of cholestasis in systemic disease can be a consequence of direct involvement of a disease process within the liver or extrahepatic biliary system or secondary to immune-mediated changes in bile flow. Evaluating a patient with cholestasis for a systemic cause requires an understanding of the patient’s risk factors, clinical setting (eg, hospitalized or immunosuppressed patient), clinical features, and pattern of laboratory abnormalities. |
format | Online Article Text |
id | pubmed-4378837 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43788372015-03-30 Systemic Causes of Cholestasis deLemos, Andrew S. Friedman, Lawrence S. Clin Liver Dis Article Systemic causes of cholestasis constitute a diverse group of diseases across organ systems. The pathophysiology of cholestasis in systemic disease can be a consequence of direct involvement of a disease process within the liver or extrahepatic biliary system or secondary to immune-mediated changes in bile flow. Evaluating a patient with cholestasis for a systemic cause requires an understanding of the patient’s risk factors, clinical setting (eg, hospitalized or immunosuppressed patient), clinical features, and pattern of laboratory abnormalities. Elsevier Inc. 2013-05 2013-01-26 /pmc/articles/PMC4378837/ /pubmed/23540504 http://dx.doi.org/10.1016/j.cld.2012.11.001 Text en Copyright © 2013 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article deLemos, Andrew S. Friedman, Lawrence S. Systemic Causes of Cholestasis |
title | Systemic Causes of Cholestasis |
title_full | Systemic Causes of Cholestasis |
title_fullStr | Systemic Causes of Cholestasis |
title_full_unstemmed | Systemic Causes of Cholestasis |
title_short | Systemic Causes of Cholestasis |
title_sort | systemic causes of cholestasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378837/ https://www.ncbi.nlm.nih.gov/pubmed/23540504 http://dx.doi.org/10.1016/j.cld.2012.11.001 |
work_keys_str_mv | AT delemosandrews systemiccausesofcholestasis AT friedmanlawrences systemiccausesofcholestasis |